Finnhub - MRNA

68 videos

Date Title Duration T A Summary Preview
Feb 18, 22:18 Moderna Loses 2 Defenses In Patent Fight N/A — — No analysis
Feb 18, 21:25 Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here? N/A — — No analysis
Feb 18, 20:56 Why Moderna (MRNA) Stock Is Trading Up Today N/A — — No analysis
Feb 18, 18:39 In reversal, US FDA will review Moderna's flu vaccine application N/A — — No analysis
Feb 18, 18:01 FDA to review Moderna’s flu jab on agency pivot N/A — — No analysis
Feb 18, 17:12 Moderna Stock Rises. FDA Will Review Its Seasonal Flu Vaccine After All. N/A — — No analysis
Feb 18, 17:06 Moderna says FDA to review its flu vaccine after reversing course N/A — — No analysis
Feb 18, 16:18 Moderna’s investigational flu vaccine moves forward in FDA review N/A — — No analysis
Feb 18, 16:10 Moderna Loses Two Defenses in Patent Infringement Case Against Arbutus Biopharma N/A — — No analysis
Feb 18, 15:22 Monkeypox Market Competitive Landscape 2026: Comprehensive Insights About 8+ Companies and 10+ Drugs N/A — — No analysis
Feb 18, 14:47 US FDA reverses course, will review Moderna's revised flu vaccine application N/A — — No analysis
Feb 18, 14:45 Moderna Says FDA Will Review Flu Vaccine, Reversing Earlier Decision. The Stock Is Rising. N/A — — No analysis
Feb 18, 14:12 FDA Reverses Course and Will Now Review Moderna’s Flu Shot N/A — — No analysis
Feb 18, 14:02 Moderna Jumps After FDA Reverses Decision On Flu Vaccine N/A — — No analysis
Feb 18, 12:00 Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission N/A — — No analysis
Feb 18, 11:17 FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal N/A — ✓ === SUMMARY === - The FDA has reversed its earlier decision and agreed to review Moderna's (MRNA) mRNA flu vaccine application, removing a significant...
Feb 18, 09:57 Moderna shares are trading higher after the company announced the FDA will initiate the review of its investigational seasonal Influenza vaccine submission. N/A — ✓ === SUMMARY === - Moderna (MRNA) shares are trading higher, up 7.10% to $47.05, following a company announcement. - The catalyst is the FDA's decision...
Feb 18, 09:24 FDA reverses course on Moderna’s flu vaccine N/A — — No analysis
Feb 18, 08:43 Moderna President Hoge Says We Hope Flu Vaccine Will Be Approved In August; Hope To Have Flu Vaccine On Market In Fall; We Did Agree To Add An Additional Post Marketing Requirement Study N/A — — No analysis
Feb 18, 08:24 Moderna's mRNA-1010 Flu Vaccine Accepted for FDA Review, With Potential Approval in 2026 N/A — — No analysis
Feb 18, 04:35 3 Stocks Under $50 with Warning Signs N/A — — No analysis
Feb 17, 15:01 The Analyst Verdict: Moderna In The Eyes Of 9 Experts N/A — — No analysis
Feb 17, 13:57 Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $41 N/A — — No analysis
Feb 17, 13:15 RBC Capital Maintains Sector Perform on Moderna, Raises Price Target to $30 N/A — — No analysis
Feb 17, 12:00 Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE N/A — — No analysis
Feb 17, 11:42 Moderna Stock Rises After EU Marketing Authorization For mNEXSPIKE N/A — — No analysis
Feb 17, 10:48 Evercore ISI Group Maintains In-Line on Moderna, Raises Price Target to $35 N/A — — No analysis
Feb 17, 08:10 The European Commission Approves Moderna's mNEXSPIKE (mRNA-1283), A New Covid Vaccine, For Active Immunization To Prevent Covid-19 In Individuals Aged 12 Years And Older N/A — — No analysis
Feb 17, 08:09 Moderna Secures Third EU-Authorized Vaccine With mNEXSPIKE, Supporting Protection Against Endemic COVID-19 As European Market Reopens In 2026 N/A — — No analysis
Feb 16, 12:48 Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders N/A — — No analysis
Feb 16, 04:47 3 Cash-Burning Stocks That Fall Short N/A — — No analysis
Feb 16, 00:20 FDA Flu Setback Tests Moderna’s mRNA Pipeline And Regulatory Assumptions N/A — — No analysis
Feb 15, 21:08 Is Moderna (MRNA) Pricing Reflecting Potential After Sharp Multi‑Year Share Price Pullback? N/A — — No analysis
Feb 13, 21:15 Moderna, Inc. Q4 2025 Earnings Call Summary N/A — ✓ # MRNA News Report — 2026-02-14 ## Overview | Metric | Value | |--------|-------| | **Ticker** | MRNA | | **Date** | 2026-02-14 | | **Total Articles...
Feb 13, 20:52 Sector Update: Health Care Stocks Advance Late Afternoon N/A — — No analysis
Feb 13, 19:16 Moderna Challenges FDA After Flu Shot Review Refusal, 26% Covid Drop N/A — — No analysis
Feb 13, 19:01 Moderna Inc (MRNA) Q4 2025 Earnings Call Highlights: Strategic Cost Reductions Amidst Financial ... N/A — — No analysis
Feb 13, 17:27 Health Care Roundup: Market Talk N/A — — No analysis
Feb 13, 17:03 Moderna shares pop on strong guidance, smaller-than-expected loss N/A — — No analysis
Feb 13, 15:27 Moderna Q4 Earnings Call Highlights N/A — — No analysis
Feb 13, 15:26 Moderna Maintains Full-Year Revenue Growth Outlook Following Fourth-Quarter Beat N/A — — No analysis
Feb 13, 15:09 Moderna Is Losing Less Money Than Expected. The Stock Jumps After Earnings. N/A — — No analysis
Feb 13, 14:39 Moderna (MRNA) Q4 2025 Earnings Call Transcript N/A — — No analysis
Feb 13, 14:10 Moderna Pops On Fourth-Quarter Report, But Can It Overcome Recent FDA Setbacks? N/A — — No analysis
Feb 13, 14:03 Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls N/A — — No analysis
Feb 13, 13:22 Moderna Inc (NASDAQ:MRNA) Beats Q4 2025 Estimates Amid Post-Pandemic Transition N/A — — No analysis
Feb 13, 13:20 Moderna Just Crushed Estimates While Everyone Was Looking the Other Way N/A — — No analysis
Feb 13, 13:20 Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates N/A — — No analysis
Feb 13, 12:56 Moderna Narrows Loss, Reiterates 10% Revenue Growth Target N/A — — No analysis
Feb 13, 12:47 Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript N/A — — No analysis
Feb 13, 12:42 Moderna beats Q4 expectations, but stock edges lower on FDA setback N/A — — No analysis
Feb 13, 12:37 Moderna shares are trading higher after the company reported better-than-expected Q4 financial results. N/A — — No analysis
Feb 13, 12:29 Moderna Reports a Narrower-Than-Expected Loss. The Stock Slips After Earnings. N/A — — No analysis
Feb 13, 12:15 Moderna: Q4 Earnings Snapshot N/A — — No analysis
Feb 13, 12:12 Moderna beats quarterly revenue estimates on resilient sales of COVID shot N/A — — No analysis
Feb 13, 12:11 Moderna (NASDAQ:MRNA) Exceeds Q4 CY2025 Expectations N/A — — No analysis
Feb 13, 12:11 FDA Flu Setback Tests Moderna Valuation And Future mRNA Vaccine Pipeline N/A — — No analysis
Feb 13, 12:00 Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates N/A — — No analysis
Feb 13, 11:59 Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms N/A — — No analysis
Feb 13, 11:56 Pharma and biotech are back, says UBS' Michael Yee N/A — — No analysis
Feb 13, 11:31 Apart From CPI Data, Here's What to Watch Friday N/A — — No analysis
Feb 13, 09:43 Moderna Exec Says Co Is "Hoping For" Approval Of The Flu-covid Combination Vaccine In Europe This Year; Awaits Us Guidance On Flu Vaccine To Refile Application For COVID-flu Combination Vaccine N/A — — No analysis
Feb 13, 08:31 Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation N/A — — No analysis
Feb 13, 08:04 Moderna Is Targeting Up To 10% Growth From 2025 Revenue And Expects 2026 Revenue Split To Be ~50% U.S. And ~50% International N/A — — No analysis
Feb 13, 08:02 Moderna Q4 Earnings Summary & Key Takeaways N/A — — No analysis
Feb 13, 08:01 Moderna Q4 EPS $(2.11) Beats $(2.59) Estimate, Sales $678.000M Beat $626.097M Estimate N/A — — No analysis
Feb 13, 03:13 Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts N/A — — No analysis
Feb 13, 00:00 January CPI, Moderna and Wendy's earnings: What to Watch N/A — — No analysis